Close Menu

NEW YORK – Hologic reported after the close of the market on Wednesday that its fiscal fourth quarter revenues rose 6 percent year over year, driven in part by growth in its medical aesthetics and molecular diagnostics businesses.

For the three months ended Sept. 30, the firm reported total revenues of $865.8 million, up from $813.5 million a year ago and beating the average consensus Wall Street estimate of $845.7 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.